跳至主導覽 跳至搜尋 跳過主要內容

Effects of PGI2 analogues on Th1- and Th2-related chemokines in monocytes via epigenetic regulation

  • Chang Hung Kuo
  • , Ying Chin Ko
  • , San Nan Yang
  • , Yu Te Chu
  • , Wei Li Wang
  • , Shau Ku Huang
  • , Huan Nan Chen
  • , Wan Ju Wei
  • , Yuh Jyh Jong
  • , Chih Hsing Hung*
  • *此作品的通信作者
  • Kaohsiung Municipal Ta-Tung Hospital
  • Kaohsiung Medical University
  • National Health Research Institutes Taiwan
  • Johns Hopkins University

研究成果: 期刊稿件文章同行評審

38 引文 斯高帕斯(Scopus)

摘要

Chemokines play important roles in asthma. Prostaglandin I2 (PGI2) analogue is recently suggested as a candidate for treating asthma. However, the effects of PGI2 analogues on the expression of Th1- and Th2-related chemokines are unknown. To this end, we investigated the in vitro effects of PGI2 analogues on the expression of Th1-related chemokine interferon-γ-inducible protein-10 (IP-10/CXCL10) and Th2-related chemokine macrophage-derived chemokine (MDC/CCL22) in human monocytes. The human monocytes were pretreated with iloprost and treprostinil before lipopolysaccharide (LPS) stimulation. IP-10 and MDC were measured by ELISA. Intracellular signaling was investigated by cyclic adenosine monophosphate (cAMP) assay, western blot and chromatin immunoprecipitation. PGI2 analogues enhanced MDC, but suppressed IP-10 expression in LPS-stimulated monocytes. These effects were reversed by the I prostanoid (IP) receptor antagonist (CAY10449), peroxisomal proliferators-activated receptor (PPAR)-α antagonist (GW6741) and PPAR-γ antagonist (GW9662). PGI2 analogues increased intracellular cAMP levels. Forskolin, an adenyl cyclase activator, conferred similar effects. PGI2 analogue-enhanced MDC expression was reduced by nuclear factor (NF) κB inhibitor (BAY 117085) and mitogen-activated protein kinase (MAPK)-p38 inhibitor (SB203580). PGI2 analogues up-regulated phospho-p65 and phospho-p38 but down-regulated phospho-ERK expression. Iloprost enhanced H3 acetylation in MDC promoter area and suppressed H3 acetylation, H3K4, and H3K36 trimethylation in IP-10 promoter area. PGI2 analogues enhanced MDC expression via the I prostanoid-receptor-cAMP, PPAR-α and PPAR-γ, NFκB-p65, MAPK-p38-ATF2 pathways and increasing histone acetylation, and suppressed IP-10 expression via the IP-receptor-cAMP, PPAR-γ, MAPK-ERK-ELK1 pathways and inhibiting histone acetylation and trimethylation in LPS-stimulated monocytes. PGI2 analogues may therefore increase Th2 recruitment and inflammation.

原文英語
頁(從 - 到)29-41
頁數13
期刊Journal of Molecular Medicine
89
發行號1
DOIs
出版狀態已出版 - 01 2011
對外發佈

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Effects of PGI2 analogues on Th1- and Th2-related chemokines in monocytes via epigenetic regulation」主題。共同形成了獨特的指紋。

引用此